Open House Drug Discount Agreements Lamivudine, Tenofovir Disoproxil And Doravirine, Atc J05Ar24

AOK BAYERN - DIE GESUNDHEITSKASSE Germany has Released a tender for Open House Drug Discount Agreements Lamivudine, Tenofovir Disoproxil And Doravirine, Atc J05Ar24 in Pharmaceuticals. The tender was released on Apr 17, 2024.

Country - Germany

Summary - Open House Drug Discount Agreements Lamivudine, Tenofovir Disoproxil And Doravirine, Atc J05Ar24

Deadline - Apr 05, 2026

MT reference number - 80989296

Product classification - Pharmaceutical products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 80989296

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: This is not an open procedure, but rather a so-called open-house model! The form for the open process is only used because there is no form for the open-house model. Contracts concluded in the open-house model are not subject to public p rocurement law due to the lack of a selection decision. The use of this form does not involve subjection to procurement regulations. AOK Bayern intends to conclude non-exclusive discount agreements with all interested pharmaceutical companies for the active ingredients lamivudine, tenofovir disoproxil and doravirine, ATC J05AR24, in accordance with Section 130a Paragraph 8 SGB V. AOK Bayern offers all interested pharmaceutical companies that meet

Mt Ref Id - 80989296

Deadline - Apr 05, 2026

Share

Similar Tenders :